LAI
VCYT icon

Legal Advantage Investments’s Veracyte VCYT Stock Holding History

Legal Advantage Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,976
Closed -$297K – 97
2025
Q2 		$297K Sell
10,976
-330
-3% -$9.56K 0.14% 87
2025
Q1 		$335K Buy
11,306
+5,000
+79% +$191K 0.18% 84
2024
Q4 		$250K Buy
+6,306
New +$239K 0.13% 94

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal Advantage Investments's VCYT Position: Q3 2025 in Review

Legal Advantage Investments sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 10,976 shares — an estimated $297K sold.

Legal Advantage Investments first reported a position in VCYT in Q4 2024 and held it in 3 quarters. The position peaked at $335K in Q1 2025. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Legal Advantage Investments reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Legal Advantage Investments sold 10,976 Veracyte shares in Q3 2025, an estimated $297K.
  • Legal Advantage Investments first reported a position in Veracyte in Q4 2024 and held it in 3 quarters.
  • Legal Advantage Investments's Veracyte position peaked at $335K in Q1 2025.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Legal Advantage Investments's 13F filing for Q3 2025, filed 20 Oct 2025.